At present, Rallybio Corp (RLYB) has a stock price of $2.45. In the previous session, the stock saw a rise, peaking at $2.46 after an opening price of $2.05. The day’s lowest price was $2.00, and it closed at $1.99.
Rallybio Corp saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $9.88 on 03/07/23, while the lowest price for the same duration was marked at $1.96 on 11/17/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of RLYB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Rallybio Corp’s current trading price is -75.19% away from its 52-week high, while its distance from the 52-week low is 25.00%. The stock’s price range during the 52-week period has remained between $1.96 and $9.88. In the Healthcare sector, the company’s shares saw a trading volume of around 0.52 million for the day, which was evidently higher than the average daily volume of 55180.0 over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Rallybio Corp (RLYB) has experienced a quarterly decline of -54.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 92.59M and boasts a workforce of 41 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.6900, with a change in price of -3.1400. Similarly, Rallybio Corp recorded 56,717 in trading volume during the last 100 days, posting a change of -56.17%.
Examining RLYB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RLYB stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
RLYB Stock Stochastic Average
Rallybio Corp’s raw stochastic average for the past 50 days is presently 12.25%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 18.56%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.69% and 3.43%, respectively.
RLYB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -62.71%.However, over the last six months, we can see a stronger performance of -63.97%. Over the last 30 days, the price of RLYB has leaped by -27.51%. And in the last five days, it has fallen by -3.54%.
